- Half Year 2024 Genus PLC Earnings Call TranscriptFeb 22, 2024€21.24 (+1.14%)Earnings
- Full Year 2023 Genus PLC Earnings Presentation (Q&A) TranscriptSep 07, 2023
- Full Year 2023 Genus PLC Pre- Recorded Earnings Presentation TranscriptSep 07, 2023
- Half Year 2023 Genus PLC Earnings Call TranscriptFeb 23, 2023€29.4Earnings
- Half Year 2023 Genus PLC Pre-Recorded Earnings Presentation TranscriptFeb 23, 2023
- Full Year 2022 Genus PLC Earnings Presentation (Q&A Session) TranscriptSep 08, 2022
- Full Year 2022 Genus PLC Earnings Presentation TranscriptSep 08, 2022
- Half Year 2022 Genus PLC Earnings Presentation (Q&A Session) TranscriptFeb 24, 2022
- Half Year 2022 Genus PLC Earnings Presentation (Pre-Recorded) TranscriptFeb 24, 2022
- Full Year 2021 Genus PLC Earnings Presentation - Q&A Session TranscriptSep 09, 2021
- Full Year 2021 Genus PLC Earnings Presentation (Pre-recorded) TranscriptSep 09, 2021
- Genus PLC Capital Markets Day TranscriptJun 22, 2021
- Interim 2021 Genus PLC Earnings Call TranscriptFeb 25, 2021€60.5 (+0.83%)Earnings
- Preliminary Q4 2020 Genus PLC Earnings Presentation (Pre-Recorded Analysts and Bankers Briefing) TranscriptSep 08, 2020
- Interim 2020 Genus PLC Earnings Presentation TranscriptFeb 27, 2020
- Preliminary 2019 Genus PLC Earnings Presentation TranscriptSep 05, 2019
- Interim 2019 Genus PLC Earnings Presentation TranscriptFeb 28, 2019
Genus PLC Capital Markets Day Transcript
Welcome to the Genus Capital Markets Event 2021. We really appreciate you spending some time with us, and we hope that you find these sessions we have for you this afternoon engaging and informative. We've got a series of presentations for you today which members of our Genus executive leadership team will be making, and we're going to have the whole team present for a live question-and-answer session after the presentations.
I'm going to pass over the usual disclaimer slide and move to a chart here which tries to put into context what we're going to be talking about today. Those of you who followed the company for some time are probably familiar with how we've talked about our business model, which you see on the right. At its center is the delivery of genetic improvement. That's our core focus. And it's illustrated on this chart by the genetic distribution curve, which you can see here shifting to the right. Today, we do this in 3 protein markets: pork, dairy and beef. And we achieve this genetic improvement through our R&D activities
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)